Nicotine Addiction Clinical Trial
Official title:
Regulation of Craving: Brief Neurocognitive Training and Neural Mechanisms
Verified date | April 2020 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators propose that brief training in regulation of craving may increase the efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based strategies may operate via different psychological and neural mechanisms.
Status | Completed |
Enrollment | 92 |
Est. completion date | July 2019 |
Est. primary completion date | July 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: 1. Between the ages of 18 and 60 2. Smoking 10 or more cigarettes per day, 3. Score >4 on the Fagerstrom Test For Nicotine Dependence (FTND) 4. Treatment seeking (motivated to quit or reduce smoking; >6 on a 10 point likert scale) 5. Fluent English speaker 6. Can commit to the full length of the protocol (~8 weeks) and 7. Are willing to be randomized to treatment condition. Exclusion Criteria: 1. Current or past comorbid Axis I disorders (assessed via the Mini Psychiatric Interview Diagnosis; MINI) 2. Current use of any psychoactive medications that have not been at a stable dose for the past 6 months, are used as mood stabilizers, or are used as smoking cessation treatments (e.g. varenicline). 3. Serious or unstable medical condition within past 6 months 4. Use of an investigational drug currently or within past 30 days 5. Use of psychoactive medications or those that affect blood flow 6. Other conditions contra-indicated for MRI (e.g., claustrophobia, presence of ferromagnetic metal in the body, prior head trauma with loss of consciousness, color blindness, hypertension, pregnancy). 7. For females only: pregnancy. |
Country | Name | City | State |
---|---|---|---|
United States | Clinical & Affective Neuroscience Lab | New Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University | National Institute on Drug Abuse (NIDA) |
United States,
Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, Carroll KM, Rounsaville BJ. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80. doi: 10.1016/j.drugalcdep.2011.05.027. Epub 2011 Jul 1. — View Citation
Carroll KM. Therapy Manuals for Drug Addiction. A Cognitive-Behavioral Approach: Treating Cocaine ?Addiction. In: Abuse NIoD, ed. Bethesda, MD: National Institute of Drug Abuse; 1998.
Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA 4th, Brewer JA. Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9. doi: 10.1016/j.drugalcdep.2012.11.015. Epub 2012 Dec 21. — View Citation
Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20. Review. — View Citation
Kober H, Kross EF, Mischel W, Hart CL, Ochsner KN. Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend. 2010 Jan 1;106(1):52-5. doi: 10.1016/j.drugalcdep.2009.07.017. Epub 2009 Sep 11. — View Citation
Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6. doi: 10.1073/pnas.1007779107. Epub 2010 Aug 2. — View Citation
Tang YY, Tang R, Posner MI. Brief meditation training induces smoking reduction. Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13971-5. doi: 10.1073/pnas.1311887110. Epub 2013 Aug 5. — View Citation
Westbrook C, Creswell JD, Tabibnia G, Julson E, Kober H, Tindle HA. Mindful attention reduces neural and self-reported cue-induced craving in smokers. Soc Cogn Affect Neurosci. 2013 Jan;8(1):73-84. doi: 10.1093/scan/nsr076. Epub 2011 Nov 22. — View Citation
Witkiewitz K, Bowen S, Douglas H, Hsu SH. Mindfulness-based relapse prevention for substance craving. Addict Behav. 2013 Feb;38(2):1563-71. doi: 10.1016/j.addbeh.2012.04.001. Epub 2012 Apr 6. Erratum in: Addict Behav. 2018 Mar 21;:. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Gender | Whether gender moderates any of the findings | 4 weeks | |
Primary | Change in Self-report Craving level | ROC task performance, as change from pre- to post- training in (1) craving (operationalized as self-reported craving on craving trials). (2) strategy-specific regulation (operationalized as scores on regulation trials using the trained strategy: LATER/control trials for CBT-based training, ACCEPT/mindfulness trials for MBT-based training). (3) strategy-non-specific regulation (scores on regulation - using the non-trained strategy: LATER trials for MBT-based training, ACCEPT trials for CBT-based training). | Baseline to 4 weeks | |
Primary | % change in craving and control related neural activity measured via functional magnetic resonance imaging (fMRI). | The neural activity component will be calculated as change from pre-to post- training during fMRI ROC task, including (1) craving- related activity (operationalized as neural reactivity in "craving regions" including Ventral Striatum, ventral medial Pre-Frontal Cortex); (2) neural substrates of control during regulation of craving (operationalized as neural activity in "control regions" including dorsal lateral and ventral lateral prefrontal cortex). | Baseline to 4 weeks | |
Primary | Change in Smoking | Measurement of reduction in cigarette smoking, measured by self report/cotinine/Carbon dioxide(CO2), and FTND smoking severity | baseline to 4 weeks | |
Secondary | Change in Cognitive Control & Affective Reactivity Behavioral Assessments | Detection of generalized effects of the training on affective reactivity and cognitive control, including: (1) Distress Tolerance, (2) CANTAB neuropsychological assessments, and (3) Drug Risk Response Task (DRRT) to measure regulation skills acquisition. | baseline to 4 weeks | |
Secondary | Change in general neural activity measured via fMRI | Determination if the effects of training generalize to other measures of cognitive control/distress tolerance, using fMRI task neural activity. | Baseline to 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02643914 -
Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
|
N/A | |
Recruiting |
NCT05530577 -
Effects of Semaglutide on Nicotine Intake
|
Phase 2 | |
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Completed |
NCT01944423 -
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
|
Early Phase 1 | |
Completed |
NCT01704573 -
Nicotinic Receptor Levels After Stopping Smoking
|
N/A | |
Active, not recruiting |
NCT01015170 -
STOP Study: Effectiveness of Zyban in a Clinical Population
|
Phase 4 | |
Completed |
NCT03281629 -
Circuitry-Guided Smoking Cessation in Schizophrenia
|
N/A | |
Recruiting |
NCT06291584 -
Effects of Exercises on Functional Capacity
|
N/A | |
Withdrawn |
NCT06259630 -
Nicotine Virtual Reality Conditioned Place Preference
|
Phase 4 | |
Completed |
NCT02624284 -
tDCS Effects on Resisting Smoking: Dose Ranging Study
|
N/A | |
Active, not recruiting |
NCT02837510 -
Neural Mechanisms Associated With Risk of Smoking Relapse
|
N/A | |
Completed |
NCT02656745 -
Clinical Trial of Smoking Cessation Mobile Phone Program
|
N/A | |
Completed |
NCT01062932 -
Investigation of Cycloserine as a Smoking Cessation Treatment
|
Phase 1 | |
Completed |
NCT03069482 -
Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness
|
Phase 1 | |
Completed |
NCT02870218 -
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
|
Phase 2 | |
Terminated |
NCT01756053 -
Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
|
Phase 2 | |
Completed |
NCT01252966 -
Cognitive Training for Nicotine Dependence
|
N/A | |
Active, not recruiting |
NCT04946825 -
Quit Smoking Study for People Who Use E-Cigarettes
|
Phase 2 | |
Recruiting |
NCT05434429 -
Mobile Health for Problematic Behaviors and Substance Use
|
N/A |